Retatrutide vs Tirzepatide vs Semaglutide

Retatrutide, tirzepatide, and semaglutide are incretin-class research peptides studied in metabolic and energy-balance models. They differ chiefly in how many incretin receptors each one engages. This reference summarizes their molecular class and the research contexts in which each is investigated — it is not medical or dosing guidance.

Aspect	Retatrutide	Tirzepatide	Semaglutide
Receptor targets	GLP-1 · GIP · glucagon (triple agonist)	GLP-1 · GIP (dual agonist)	GLP-1 (mono agonist)
Compound class	Synthetic incretin tri-agonist peptide	Synthetic incretin co-agonist peptide	GLP-1 receptor agonist analog
Primary research focus	Energy balance & metabolic signaling	Glucose-handling & metabolic models	Appetite & glucoregulatory pathways
Format	Lyophilized powder, sealed	Lyophilized powder, sealed	Lyophilized powder, sealed

Why receptor count matters in the literature

The three compounds are often grouped by how many incretin receptors they activate. Semaglutide is studied as a single-receptor (GLP-1) agonist; tirzepatide adds GIP activity; retatrutide adds glucagon-receptor activity on top of both. Researchers select among them when a model calls for single- versus multi-pathway incretin signaling.

Handling and storage

All three are supplied as lyophilized powder in sealed vials. Store lyophilized material cold and protected from light, and follow standard peptide-handling practice in the lab.

View Retatrutide View Tirzepatide View Semaglutide

Questions

What is the difference between retatrutide, tirzepatide, and semaglutide?

They differ by incretin-receptor coverage: semaglutide targets GLP-1 only, tirzepatide targets GLP-1 and GIP, and retatrutide targets GLP-1, GIP, and the glucagon receptor. All three are studied in metabolic research models.

Are these the same compound?

No. They are distinct synthetic peptides with different sequences and different receptor-binding profiles, though all sit in the incretin research class.

How are they supplied?

Each is supplied as lyophilized powder. All compounds are sold strictly For Research Use Only — not for human or animal consumption, and not intended to diagnose, treat, cure, or prevent any disease.

For Research Use Only. Not for human or animal consumption. The above is a neutral summary of compound class and published research context; it is not medical, dosing, or usage guidance, and has not been evaluated by the Food and Drug Administration.